Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

CLDX Quote, Trading Chart, Celldex Therapeutics Inc.


home / stock / cldx / cldx quote

$25.20 Last:

-4.98% Change Percent:

$25.69 Open:

$25.20 Previous Close:

$26.64 High:

$24.18 Low:

640,162 Volume:

03/04/2021 04:55:23 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-03-0425.6925.226.6424.18640,162
2021-03-0329.926.5229.9426.51457,881
2021-03-0228.6329.9130.1728.5397,238
2021-03-0127.4428.1928.527.44423,923
2021-02-2627.5827.0828.0226.46423,450
2021-02-2527.9827.5128.7927.04678,306
2021-02-2427.5927.7528.0526.795581,984
2021-02-2328.7127.7128.7125.84821,369
2021-02-2227.7328.2529.326.48895,954
2021-02-1927.2527.8928.1226.92575,140
2021-02-1825.5626.6526.7125.07851,892
2021-02-1724.8925.626.0724.505950,818
2021-02-1624.6925.2525.3724.06733,673
2021-02-1523.524.324.9623.3448,878
2021-02-1223.524.324.9623.3448,767
2021-02-1123.1923.7524.1622.75455,627
2021-02-1022.5522.8223.421.975469,173
2021-02-0924.3522.524.5422.34529,653
2021-02-0824.0224.2125.7323.84689,979
2021-02-0523.75523.824.4823.11461,092
Stock Information

Celldex Therapeutics Inc. Company Name:

CLDX Stock Symbol:

NASDAQ Market:

Celldex Therapeutics Inc. Website:

MENU
CLDX CLDX Quote CLDX Short CLDX News CLDX Articles CLDX Message Board
Get CLDX Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT CLDX NEWS
  • CLDX - Celldex Therapeutics to Expand Development of CDX-0159 into Prurigo Nodularis (PN)

    --Dermatological indication characterized by chronic, intensely itchy nodules; mast cell activation believed to play an important role in amplifying chronic itch and neuroinflammation-- --Potential to expand future CDX-0159 development beyond chronic urticarias to chronic pruritic d...

  • CLDX - Celldex Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference

    HAMPTON, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that the Company will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 2:20 p.m. ET. A webcast of the ...

  • CLDX - Top Picks 2021- Celldex Therapeutics CLDX

    Celldex Therapeutics (CLDX) has developed CDX-0159, an anti-C-KIT antibody that has blockbuster potential in various mast cell diseases, explains biotech expert Jay Silverman, contributing editor to The Medical Technology Stock Letter. For further details see: Top Picks 2021- Celldex Th...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News